MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia

We identified mutations in the IL7Ra gene or in genes encoding the downstream signaling molecules JAK1, JAK3, STAT5B, N-RAS, K-RAS, NF1, AKT and PTEN in 49% of patients with pediatric T-cell acute lymphoblastic leukemia (T-ALL). Strikingly, these mutations (except RAS/NF1) were mutually exclusive, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Canté-Barrett, K, Spijkers-Hagelstein, J A P, Buijs-Gladdines, J G C A M, Uitdehaag, J C M, Smits, W K, van der Zwet, J, Buijsman, R C, Zaman, G J R, Pieters, R, Meijerink, J P P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240021/
https://www.ncbi.nlm.nih.gov/pubmed/27174491
http://dx.doi.org/10.1038/leu.2016.83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240021/
https://www.ncbi.nlm.nih.gov/pubmed/27174491
http://dx.doi.org/10.1038/leu.2016.83

Ejemplares similares